Cefonicid

• UNSPSC Description:

  Pharmacokinetic studies of Cefonicid have shown that high blood concentrations can be achieved rapidly after intravenous and intramuscular injection, and that concomitant use of albendazole prolongs its half-life in the body and reduces the rate of renal excretion[1].

• Target Antigen:

  Others

• Type:

  Reference compound

• Related Pathways:

  Others

• Field of Research:

  Others

• Assay Protocol:

  https://www.medchemexpress.com/cefonicid.html

• Smiles:

  O=C(O)C(N12)=C(CSC3=NN=NN3CS(=O)(O)=O)CS[C@]2([H])[C@H](NC([C@H](O)C4=CC=CC=C4)=O)C1=O

• Molecular Weight:

  542.57

• References & Citations:

  [1]Pitkin D, et al. Kinetics and renal handling of cefonicid[J]. Clinical Pharmacology & Therapeutics, 1981, 30(5): 587-593.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  Launched

• CAS Number:

  61270-58-4